NoticeThis is an independent non-profit initiative. We are not affiliated with the European Medicines Agency (EMA) or the official CTIS system. For the official EU Clinical Trials Information System, visit:
EMA Registry →
Phase 1a Monotherapy Dose Escalation and Exploration: HER2 mutant, HER2 amplified or HER2 positive solid tumor
Phase 1a Dose Escalation Combination with T-DXd: HER2 mutant Non-small Cell Lung Cancer
Phase 1a Dose Escalation Combination with T-DM1: HER2 positive Metastatic Breast Cancer
Phase 1b Monotherapy Dose Expansion: HER2 mutant Non-small Cell Lung Cancer
1 total trials
Filter these 1 trials by phase, country, sponsor and more.